FibroGen(FGEN) - 2023 Q4 - Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Conference Call February 26, 2024 5:00 PM ET Company Participants David DeLucia - Head of Corporate FP&A / Investor Relations Thane Wettig - Chief Executive Officer John Hunter - Chief Scientific Officer Juan Graham - Chief Financial Officer Conference Call Participants Andy Hsieh - William Blair Paul Choi - Goldman Sachs Operator Thank you for standing by and welcome to FibroGen's Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instruction ...